MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Earnings & Estimates
NASDAQ:MDGL - US5588681057 - Common Stock
412.23 USD
-2.45 (-0.59%)
412.23 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.133M | 890.07M 394.12% | 1.404B 57.74% | 2.094B 49.15% | 2.932B 40.02% | 3.972B 35.47% | 4.583B 15.38% | 5.225B 14.01% | 4.637B -11.25% | |||
| EBITDA YoY % growth | -293.13M -21.08% | -379.969M -29.62% | -496.779M -30.74% | -370.176M 25.48% | -73.496M 80.15% | 428.76M 683.38% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -293.6M -21.07% | -380.496M -29.60% | -497.875M -30.85% | -323.534M 35.02% | -13.797M 95.74% | 503.09M 3,746.30% | 1.356B 169.53% | 2.37B 74.78% | 2.943B 24.18% | 3.274B 11.25% | 3.264B -0.31% | |
| Operating Margin | N/A | N/A | -276.39% | -36.35% | -0.98% | 24.03% | 46.25% | 59.67% | 64.22% | 62.66% | 70.39% | |
| EPS YoY % growth | -17.23 -17.93% | -19.94 -15.73% | -22.11 -10.88% | -10.67 51.76% | 1.99 118.62% | 20.01 907.44% | 42.60 112.86% | 73.94 73.57% | 87.99 19.00% | 102.96 17.02% | 91.36 -11.27% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.23 54.61% | -2.59 4.60% | -0.45 86.48% | 1.05 155.17% | 2.45 209.53% | 4.74 283.17% |
| Revenue Q2Q % growth | 244.81M 293.74% | 279.87M 170.88% | 276.85M 101.71% | 333.02M 56.49% | 368.54M 50.54% | 438.41M 56.65% |
| EBITDA Q2Q % growth | -35.404M 69.37% | -80.585M -22.28% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -57.628M 50.45% | -63.272M 5.56% | 15.583M 119.65% | 50.479M 206.94% | 82.905M 243.86% | 129.33M 304.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.90 73.24% | -3.71 | 1.81 | 48.79% |
| Q1 2025 Q2Q % growth | -3.32 55.01% | -3.84 | 0.52 | 13.46% |
| Q4 2024 Q2Q % growth | -2.71 52.29% | -4.33 | 1.62 | 37.40% |
| Q3 2024 Q2Q % growth | -4.92 7.87% | -7.05 | 2.13 | 30.22% |
| Q2 2024 Q2Q % growth | -7.10 -51.39% | -7.68 | 0.58 | 7.50% |
| Q1 2024 Q2Q % growth | -7.38 -74.47% | -6.41 | -0.97 | -15.12% |
| Q4 2023 Q2Q % growth | -5.68 -14.06% | -5.39 | -0.29 | -5.38% |
| Q3 2023 Q2Q % growth | -5.34 -12.42% | -5.02 | -0.32 | -6.30% |
| Q2 2023 Q2Q % growth | -4.69 -13.29% | -4.67 | -0.02 | -0.37% |
| Q1 2023 Q2Q % growth | -4.23 -25.89% | -5.04 | 0.81 | 16.00% |
| Q4 2022 Q2Q % growth | -4.98 -31.75% | -4.65 | -0.33 | -7.16% |
| Q3 2022 Q2Q % growth | -4.75 -25.33% | -4.24 | -0.51 | -12.11% |
| Q2 2022 Q2Q % growth | -4.14 -11.29% | -3.77 | -0.37 | -9.78% |
| Q1 2022 Q2Q % growth | -3.36 -1.20% | -3.69 | 0.33 | 9.02% |
| Q4 2021 Q2Q % growth | -3.78 1.05% | -3.95 | 0.17 | 4.41% |
| Q3 2021 Q2Q % growth | -3.79 -1.07% | -3.98 | 0.19 | 4.67% |
| Q2 2021 Q2Q % growth | -3.72 -16.98% | -3.66 | -0.06 | -1.75% |
| Q1 2021 Q2Q % growth | -3.32 -41.88% | -3.92 | 0.60 | 15.32% |
| Q4 2020 Q2Q % growth | -3.82 -112.22% | -3.93 | 0.11 | 2.85% |
| Q3 2020 Q2Q % growth | -3.75 -169.78% | -3.36 | -0.39 | -11.47% |
| Q2 2020 Q2Q % growth | -3.18 -148.44% | -2.50 | -0.68 | -27.07% |
| Q1 2020 Q2Q % growth | -2.34 -138.78% | -1.98 | -0.36 | -18.07% |
| Q4 2019 Q2Q % growth | -1.80 | -1.68 | -0.12 | -6.99% |
| Q3 2019 Q2Q % growth | -1.39 | -1.57 | 0.18 | 11.19% |
| Q2 2019 Q2Q % growth | -1.28 | -1.22 | -0.06 | -4.64% |
| Q1 2019 Q2Q % growth | -0.98 | -0.99 | 0.01 | 0.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 212.802M 1,353.76% | 165.56M | 47.242M | 28.53% |
| Q1 2025 Q2Q % growth | 137.25M | 116.1M | 21.15M | 18.22% |
| Q4 2024 Q2Q % growth | 103.32M | 100.53M | 2.79M | 2.78% |
| Q3 2024 Q2Q % growth | 62.175M | 34.873M | 27.302M | 78.29% |
| Q2 2024 Q2Q % growth | 14.638M | 3.981M | 10.657M | 267.70% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 36.58% | 33.96% | 21.21% | 17.44% |
| Revenue | 32.17% | 56.81% | 27.95% | 28.2% |